Kevin Biglan
Eli Lilly (United States)(US)University of Rochester Medical Center(US)Centre for Movement Disorders(CA)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases, Neurological disorders and treatments, Mitochondrial Function and Pathology, Telemedicine and Telehealth Implementation
Most-Cited Works
- → Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home(2017)3,179 cited
- → Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030(2006)2,448 cited
- → Detection of Huntington's disease decades before diagnosis: the Predict-HD study(2007)807 cited
- → CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion(2012)386 cited
- → Neurocognitive signs in prodromal Huntington disease.(2010)373 cited
- → Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study(2015)372 cited